Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Pharmacodynamics of Digoxin in Infants With Single Ventricle Heart Disease
NCT06613477Phase 2Completed
- Sponsor
- Duke University
- Start
- Oct 2024
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in Single Ventricle Congenital Heart Disease (SVCHD), sponsored by Duke University. Started Oct 2024; status: completed.
02
Drugs
digoxin
03
Conditions
Single Ventricle Congenital Heart Disease (SVCHD)
Beyond the preview
Go deeper on NCT06613477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06613477.